Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial.
Lancet Respir Med
; 9(12): 1427-1438, 2021 12.
Article
in En
| MEDLINE
| ID: mdl-34756178
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Respiratory Insufficiency
/
Antibodies, Monoclonal, Humanized
/
Cytokine Release Syndrome
/
COVID-19 Drug Treatment
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Lancet Respir Med
Year:
2021
Type:
Article